SCIENTIFIC TALK AMD | Neuropatia diabetica | 15 novembre – ore 17 Share Post navigation A statistical approach for assessing the compliance of integrated continuous glucose monitoring systems with FDA accuracy requirementsRischio cardiovascolare nel diabete tipo 1 e tipo 2: due pesi e due misure?
